Preferred Label : Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant
4;
Symbol : PEOA4;
CISMeF acronym : PEOA4;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Progressive external ophthalmoplegia, autosomal dominant 4;
Description : Progressive external ophthalmoplegia-4 is an autosomal dominant form of mitochondrial
disease that variably affects skeletal muscle, the nervous system, the liver, and
the gastrointestinal tract. Age at onset ranges from infancy to adulthood. The phenotype
ranges from relatively mild, with adult-onset skeletal muscle weakness and weakness
of the external eye muscles, to severe, with a multisystem disorder characterized
by delayed psychomotor development, lactic acidosis, constipation, and liver involvement
(summary by Young et al., 2011). For a general phenotypic description and a discussion
of genetic heterogeneity of autosomal dominant progressive external ophthalmoplegia,
see PEOA1 (157640).;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutation in the DNA polymerase gamma-2 gene (POLG2, 604983.0001);
Laboratory abnormalities : Increased serum lactate; Increased serum creatine kinase; Abnormal liver enzymes (in some patients);
Prefixed ID : #610131;
Origin ID : 610131;
UMLS CUI : C1864668;
Automatic exact mappings (from CISMeF team)
Broader ORDO disease(s)
CISMeF manual mappings
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)